Skip to main content
. 2022 Feb 1;12(2):239. doi: 10.3390/biom12020239

Figure 3.

Figure 3

ErbB2 expression is modulated by M2 agonist APE. (A) qRT-PCR analysis shows the decreased expression of erbB2 receptor transcripts after 16 h of APE treatment (APE 16 h: *** p < 0.001; n = 3); (B) Representative Western blotting showing the decreased expression of erbB2 receptor after 16 and 24 h of APE treatment; the graph represents the average of the OD ± SEM of the bands normalized against the reference protein (**** p < 0.0001; n = 3). Calreticulin was used as reference protein considering the prevalent accumulation of erbB2 receptors in endoplasmic reticulum (ER) after APE treatment.